UXV-10159-75433
2 vaccinations
2 coded responses
10 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 481 / MI
- Registered
- 2021-12-02
- Relationship
- Child or adolescent in my care
- Guardian
- T6Z-33692-28691
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-30
Dose 1 — Pfizer-BioNTech
-
2021-12-02
Registered in v-safe
-
2021-12-04
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-12-07
- 2021-12-14
- 2021-12-21
-
2021-12-23
Dose 2 — Pfizer-BioNTech
-
2022-01-06
Survey response — day 14, dose 2, dependentMedDRA: Headache — Feeling: Fair · Be unable to work or attend schoolFree text: HeadacheMedDRA releases: 2024-11 · check-in free text available
- 2022-01-13
- 2022-01-20
- 2022-01-27
-
2022-02-03
Survey response — day 42, dose 2, dependentMedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-03-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-30 | Pfizer-BioNTech | No |
| 2 | 2021-12-23 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 2, dependent
Symptoms: Headache
Release 11 — day 42, dose 2, dependent
Symptoms: Runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release